Download Sample
Add to CartGlobal Artificial Retina Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Epiretinal Implants, Subretinal Implants, Suprachoroidal Implants, and Others.By Retinal Prosthesis Devices;
Photovoltaic Retinal Prosthesis, and Microelectronic Retinal Prosthesis.By Visual Prosthesis;
Standalone Visual Prosthesis, and Combination Visual Prosthesis.By Mechanical Technology;
Subretinal Implants, and Epiretinal Implants.By End-Use;
Hospitals, Ophthalmic Clinics, Research Institutes, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Artificial Retina Market (USD Million), 2021 - 2031
In the year 2024, the Global Artificial Retina Market was valued at USD 21,939.85 million. The size of this market is expected to increase to USD 98,340.61 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 23.9%.
The global artificial retina market is witnessing a significant surge in growth, fueled by advancements in medical technology and the rising prevalence of retinal disorders worldwide. The artificial retina, also known as a retinal prosthesis, is a cutting-edge innovation designed to restore vision in individuals with severe vision impairment or blindness caused by retinal diseases such as retinitis pigmentosa and age-related macular degeneration (AMD).
This revolutionary technology aims to mimic the functionality of the natural retina by electrically stimulating the remaining viable retinal cells, thereby inducing visual perception. The artificial retina system typically consists of a microelectrode array implanted on the surface of the retina, a microchip that processes visual information, and an external device, such as glasses or a wearable camera, which captures images and transmits them to the implant.
One of the key drivers propelling the growth of the artificial retina market is the increasing incidence of retinal disorders, particularly among the aging population. With the global demographic shift towards an older population, the prevalence of age-related eye diseases is expected to escalate, driving the demand for advanced treatment options such as artificial retinas.
Technological advancements and ongoing research efforts are enhancing the efficacy and safety of artificial retina devices, making them more accessible and reliable for patients. Miniaturization of implant components, improvements in electrode design, and development of wireless communication systems are among the key technological innovations driving the evolution of artificial retina technology.
Growing investments in healthcare infrastructure, coupled with favorable government initiatives and supportive reimbursement policies, are fostering the adoption of artificial retina devices across various healthcare settings. Furthermore, collaborations between academic institutions, research organizations, and industry players are accelerating the pace of innovation in this field, leading to the introduction of next-generation artificial retina solutions with enhanced performance and functionality.
Despite the promising growth prospects, the artificial retina market still faces certain challenges, including high treatment costs, regulatory hurdles, and the need for long-term clinical evidence to establish the safety and efficacy of these devices. Moreover, the complex nature of retinal diseases and the variability in patient responses pose significant challenges for developers and clinicians in optimizing the outcomes of artificial retina implants.
The global artificial retina market is poised for robust growth in the coming years, driven by technological advancements, rising prevalence of retinal disorders, and increasing investments in healthcare infrastructure. As researchers continue to push the boundaries of innovation and clinicians gain more experience with these devices, artificial retinas are likely to become a mainstream treatment option for individuals with severe vision impairment, ultimately improving their quality of life and visual outcomes.
Global Artificial Retina Market Recent Developments
-
In 2022, Nidek Co., Ltd., a manufacturer and distributor specializing in ophthalmic devices, acquired Nidek Medical S.R.L., gaining 90% equity ownership. This deal aimed to strengthen collaboration between Nidek Medical and Nidek, enhancing their overall performance.
-
In 2021, Bionic Vision Technologies announced a partnership with Cirtec Medical, a U.S.-based company, to develop an advanced bionic eye system.
Segment Analysis
The global artificial retina market is segmented by type, which includes retinal prosthesis devices and visual prosthesis. Retinal prosthesis devices are designed to restore vision in individuals with retinal degenerative diseases, such as retinitis pigmentosa, by stimulating the retina directly using an array of electrodes. These devices can provide partial vision restoration by bypassing damaged photoreceptors. Visual prosthesis, a broader category, includes devices aimed at improving or restoring vision through various means, such as electronic implants, retinal implants, and wearable devices that enhance the visual input for patients with severe vision impairments. Both categories are integral to the market, with continued research leading to more sophisticated solutions to address different stages and types of vision loss.
The mechanical technology segment focuses on the development of more advanced devices for artificial retinal and visual prosthesis solutions. This includes technologies that use microelectromechanical systems (MEMS), electrode arrays, and image-processing units to improve the resolution and functionality of retinal implants. MEMS and electrode arrays are key components used in retinal prosthesis devices, helping to stimulate the remaining healthy retinal cells for visual perception. Advances in image-processing technology are crucial for improving the quality of vision restoration by converting visual information into electrical signals that the brain can interpret. The integration of mechanical and software technologies has the potential to significantly enhance the performance of artificial retina systems, providing patients with better visual clarity and autonomy.
The end-use segment of the artificial retina market includes hospitals, ophthalmology clinics, and homecare settings. Hospitals are major users of artificial retina technologies, where retinal implants and visual prosthesis devices are surgically implanted in patients, often as part of a comprehensive treatment plan for retinal diseases. Ophthalmology clinics also play a vital role, offering specialized consultations, assessments, and post-operative care for patients considering retinal prosthetics. As the technology becomes more user-friendly, homecare settings are witnessing growing adoption, particularly with the development of non-invasive wearable visual prostheses that assist patients in their daily lives. Geographically, North America leads the market, driven by advanced healthcare systems, research, and higher rates of adoption of new medical technologies. Europe follows closely, with strong healthcare infrastructure and increasing demand for retinal prosthetics. The Asia-Pacific region is expected to experience rapid growth, fueled by rising awareness, improving healthcare access, and the growing prevalence of age-related macular degeneration and other retinal diseases.
Global Artificial Retina Segment Analysis
In this report, the Global Artificial Retina Market has been segmented by Type, Retinal Prosthesis Devices, Visual Prosthesis, Mechanical Technology, End-Use and Geography.
Global Artificial Retina Market, Segmentation by Type
The Global Artificial Retina Market has been segmented by Type into Epiretinal Implants, Subretinal Implants, Suprachoroidal Implants and Others.
The global artificial retina market has witnessed significant growth in recent years, driven by advancements in medical technology and increasing prevalence of retinal diseases leading to vision impairment. The market is segmented by type into epiretinal implants, subretinal implants, suprachoroidal implants, and others, each offering unique solutions for restoring vision in individuals with retinal degenerative diseases.
Epiretinal implants, which are placed on the surface of the retina, have gained prominence due to their effectiveness in stimulating retinal cells and transmitting visual signals to the brain. These implants typically consist of a microelectrode array that interfaces with the remaining retinal tissue, providing artificial vision to individuals with conditions such as retinitis pigmentosa or age-related macular degeneration.
Subretinal implants, on the other hand, are positioned beneath the retina and directly stimulate the remaining functional retinal cells. This approach offers potential benefits in terms of visual acuity and spatial resolution, making it a promising option for patients with advanced retinal degeneration.
Suprachoroidal implants represent a relatively newer development in the field of artificial retina technology. Placed between the choroid and sclera, these implants aim to stimulate the retina indirectly by modulating the neural activity in the adjacent retinal layers. While still in the early stages of development, suprachoroidal implants hold promise for overcoming some of the challenges associated with epiretinal and subretinal approaches.
These primary types, the market also encompasses various other technologies and approaches aimed at restoring vision in individuals with retinal diseases. These may include innovative electrode designs, advanced materials, or novel surgical techniques aimed at optimizing implant placement and function.
The global artificial retina market is characterized by ongoing research and development efforts aimed at improving the efficacy, safety, and accessibility of retinal implants. With continued innovation and investment in this field, artificial retina technologies hold the potential to significantly enhance the quality of life for millions of individuals worldwide affected by retinal degenerative diseases.
Global Artificial Retina Market, Segmentation by Retinal Prosthesis Devices
The Global Artificial Retina Market has been segmented by Retinal Prosthesis Devices into Photovoltaic Retinal Prosthesis and Microelectronic Retinal Prosthesis.
The global artificial retina market is witnessing significant growth, primarily driven by advancements in retinal prosthesis devices. Within this market, two main types of retinal prostheses are making strides: photovoltaic retinal prostheses and microelectronic retinal prostheses.
Photovoltaic retinal prostheses utilize light-sensitive elements to convert incoming light into electrical signals, stimulating the remaining functional retinal cells. This technology offers a promising solution for individuals with retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration.
On the other hand, microelectronic retinal prostheses involve implanting microelectrode arrays directly onto the retina, bypassing damaged photoreceptor cells and directly stimulating the remaining retinal neurons. This approach aims to restore vision by bypassing the dysfunctional components of the visual pathway.
The growing prevalence of age-related eye disorders, coupled with the increasing demand for innovative solutions to restore vision, is fueling the expansion of the artificial retina market. Additionally, ongoing research and development efforts are focused on enhancing the efficacy, safety, and affordability of these retinal prostheses to address the diverse needs of patients worldwide.
Collaborations between academic institutions, research organizations, and healthcare companies are driving advancements in artificial retina technology, leading to the introduction of novel therapies and devices in the market.
As the global population continues to age and the prevalence of vision-related disorders rises, the artificial retina market is poised for further expansion. Continued innovation and investment in research and development are expected to drive the market forward, offering hope to millions of individuals suffering from vision impairment.
Global Artificial Retina Market, Segmentation by Visual Prosthesis
The Global Artificial Retina Market has been segmented by Visual Prosthesis into Standalone Visual Prosthesis and Combination Visual Prosthesis.
The global artificial retina market is witnessing significant growth driven by advancements in visual prosthetic technologies. Visual prostheses are becoming increasingly sophisticated, offering standalone and combination solutions to address various degrees of visual impairment.
Standalone visual prostheses are designed to directly stimulate the remaining functional cells in the retina or bypass damaged cells to send visual signals to the brain. These devices hold immense promise for individuals with conditions such as retinitis pigmentosa and age-related macular degeneration, offering the potential to restore partial vision.
On the other hand, combination visual prostheses integrate with other technologies, such as external cameras or sensors, to enhance visual perception. These systems leverage advanced image processing algorithms to capture and interpret visual information, which is then translated into electrical impulses for the retina or optic nerve.
The market for both standalone and combination visual prostheses is experiencing robust growth due to increasing research and development efforts, rising prevalence of vision disorders, and growing investments in healthcare infrastructure. Moreover, the integration of artificial intelligence and machine learning algorithms is further augmenting the capabilities of visual prosthetic devices, improving their accuracy and effectiveness.
Challenges such as high costs, regulatory hurdles, and the need for long-term efficacy studies remain significant barriers to widespread adoption. Nonetheless, with ongoing technological innovations and expanding applications, the global artificial retina market is poised for continued expansion, offering hope to millions of individuals worldwide living with visual impairment.
Global Artificial Retina Market, Segmentation by Mechanical Technology
The Global Artificial Retina Market has been segmented by Mechanical Technology into Subretinal Implants and Epiretinal Implants.
The global artificial retina market is experiencing significant growth, driven by advancements in mechanical technology and the development of innovative implantable devices such as subretinal and epiretinal implants. These cutting-edge technologies are revolutionizing the field of ophthalmology by offering new hope to individuals suffering from retinal diseases like retinitis pigmentosa and age-related macular degeneration (AMD).
Subretinal implants are designed to be placed beneath the retina, directly stimulating the remaining functional retinal cells to restore vision. These implants typically consist of a microelectronic chip and an array of electrodes, which interface with the retinal cells to bypass damaged photoreceptors and transmit visual signals to the brain. The growing adoption of subretinal implants is attributed to their ability to provide high-resolution vision and improve visual acuity in patients with severe retinal degeneration.
On the other hand, epiretinal implants are positioned on the surface of the retina and function by directly stimulating the remaining retinal ganglion cells. These implants typically include a small camera mounted on eyeglasses or a headband, which captures visual information and transmits it wirelessly to the implant. Epiretinal implants offer advantages such as flexibility in visual processing and compatibility with various retinal conditions, making them a promising solution for restoring sight in individuals with different degrees of retinal damage.
The market for artificial retinas is witnessing rapid expansion due to the increasing prevalence of retinal diseases, rising awareness about available treatment options, and growing investments in research and development. Moreover, technological advancements aimed at enhancing the performance and longevity of artificial retina implants are fueling market growth further. However, challenges such as the high cost of treatment, limited reimbursement policies, and the need for long-term efficacy studies pose significant hurdles to market penetration.
The global artificial retina market is poised for continued growth, driven by advancements in mechanical technology and the availability of innovative implantable devices such as subretinal and epiretinal implants. As these technologies continue to evolve and improve, they hold the potential to significantly impact the lives of millions of individuals worldwide affected by retinal diseases, offering them renewed hope for a brighter future.
Global Artificial Retina Market, Segmentation by End-Use
The Global Artificial Retina Market has been segmented by End-Use into Hospitals, Ophthalmic Clinics, Research Institutes and Others.
The global artificial retina market is experiencing significant growth driven by advancements in medical technology and increasing prevalence of retinal disorders. Artificial retinas, also known as retinal implants, are designed to restore vision in individuals with retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration.
Hospitals represent a substantial end-use segment for artificial retinas, as they serve as primary centers for the diagnosis and treatment of retinal disorders. The availability of advanced surgical facilities and skilled medical professionals in hospitals contribute to the adoption of artificial retinal implants as a viable treatment option for patients.
Ophthalmic clinics also play a crucial role in the artificial retina market, offering specialized services for the diagnosis and management of various eye conditions. These clinics often have dedicated teams of ophthalmologists and retina specialists who are at the forefront of utilizing innovative technologies, including artificial retinal implants, to improve patient outcomes.
Research institutes are pivotal in driving advancements in artificial retina technology through rigorous scientific research and clinical trials. Collaborations between research institutions, medical device companies, and healthcare professionals facilitate the development of novel implantable devices with enhanced functionality and improved safety profiles.
Other end-use segments encompass a diverse range of healthcare settings, including ambulatory surgical centers and specialty eye care facilities. These settings cater to patients with specific needs and preferences, contributing to the overall growth and diversification of the artificial retina market.
The global artificial retina market is characterized by a diverse array of end-use segments, each playing a vital role in advancing the adoption and utilization of retinal implant technology. Continued innovation, coupled with expanding applications and increasing awareness among healthcare providers and patients, is expected to drive further growth in this dynamic market.
Global Artificial Retina Market, Segmentation by Geography
In this report, the Global Artificial Retina Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Artificial Retina Market Share (%), by Geographical Region, 2024
The global artificial retina market, segmented by geography, showcases a dynamic landscape influenced by technological advancements, healthcare infrastructure, and regulatory frameworks across different regions. North America, comprising the United States and Canada, holds a significant share in this market owing to robust research and development activities, a strong healthcare system, and a high prevalence of retinal diseases. The presence of key market players and favorable reimbursement policies further bolsters the growth of the artificial retina market in this region.
Europe emerges as another prominent market for artificial retina technologies, with countries like Germany, the UK, and France leading the way. The region benefits from advanced medical infrastructure, a growing geriatric population, and increasing awareness regarding vision care. Additionally, supportive government initiatives and rising investments in healthcare contribute to market expansion.
Asia-Pacific represents a rapidly growing market for artificial retina technologies, driven by improving healthcare infrastructure, increasing disposable income, and a rising prevalence of retinal disorders in countries like China, Japan, and India. Moreover, strategic collaborations between local and international players and a growing emphasis on technological innovation propel market growth in this region.
Latin America and the Middle East & Africa are also witnessing steady growth in the artificial retina market, albeit at a slower pace compared to other regions. Factors such as expanding healthcare access, rising healthcare expenditure, and a growing focus on addressing vision impairment contribute to market development in these regions.
The global artificial retina market's segmentation by geography reflects diverse growth opportunities and challenges influenced by regional socioeconomic factors, healthcare policies, and technological advancements. Collaborative efforts among stakeholders and continued innovation are essential to further propel market growth and address the unmet needs of patients with retinal disorders worldwide.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Artificial Retina Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Research and development
- Healthcare infrastructure
- Government initiatives
-
Reimbursement policies -Reimbursement policies play a crucial role in shaping the adoption and accessibility of artificial retina devices in the global market. The reimbursement landscape varies significantly from country to country and can impact both patients and healthcare providers.
In many developed countries, such as the United States, reimbursement for artificial retina devices is often facilitated through government healthcare programs like Medicare and private health insurance plans. These reimbursement policies typically involve a process where healthcare providers submit claims for the cost of the device and associated procedures, and reimbursement is provided based on established fee schedules or negotiated rates.
The reimbursement landscape for artificial retina devices can be complex due to factors such as the high cost of the technology, variability in coverage criteria, and the need for specialized surgical expertise. In some cases, coverage may be limited to certain patient populations, such as those with specific diagnoses or severity of vision loss.
Reimbursement policies may evolve over time in response to changes in clinical evidence, healthcare economics, and regulatory frameworks. For example, as more data becomes available on the long-term efficacy and cost-effectiveness of artificial retina devices, reimbursement policies may be adjusted to reflect these findings.
In regions with publicly funded healthcare systems, such as many European countries, reimbursement decisions for artificial retina devices may be made by government health authorities based on assessments of clinical effectiveness, safety, and cost-effectiveness. These decisions can influence the availability and accessibility of artificial retina technology within these healthcare systems.
Reimbursement policies are a critical consideration for stakeholders in the artificial retina market, including manufacturers, healthcare providers, and patients. Efforts to streamline reimbursement processes, improve coverage transparency, and demonstrate the value of artificial retina technology through robust clinical evidence will be important for ensuring equitable access to these innovative treatments.
Restraints:
- High treatment costs
- Long-term clinical evidence
- Variability in patient responses
-
Complex nature of retinal diseases -The global artificial retina market is shaped by the complex nature of retinal diseases, which present diverse challenges and necessitate innovative solutions for vision restoration. Retinal diseases encompass a broad spectrum of conditions, including retinitis pigmentosa, age-related macular degeneration, diabetic retinopathy, and others, each with unique pathophysiological mechanisms and clinical manifestations.
One of the key complexities inherent in retinal diseases is the progressive nature of vision loss. Patients often experience gradual deterioration in visual acuity and peripheral vision, leading to significant impairment in daily activities and quality of life. Moreover, the underlying causes of retinal diseases can vary widely, ranging from genetic mutations to age-related changes or systemic conditions such as diabetes.
Another complexity stems from the heterogeneous nature of retinal degeneration within individual patients. Even among individuals diagnosed with the same retinal disease, there can be considerable variability in disease progression, severity, and response to treatment. This variability poses challenges for developing standardized approaches to diagnosis and management and underscores the need for personalized treatment strategies tailored to each patient's unique characteristics.
The anatomy and physiology of the retina itself contribute to the complexity of treating retinal diseases. The retina is a highly specialized tissue composed of multiple layers of neural cells responsible for processing visual information. Damage to any of these layers can disrupt the transmission of visual signals to the brain, resulting in vision loss. Restoring vision requires not only addressing the underlying cause of retinal damage but also overcoming the intricate neural circuitry and functional deficits associated with the disease.
Artificial retina technologies play a crucial role in addressing the complexity of retinal diseases by providing alternative pathways for visual input to the brain. By bypassing damaged retinal tissue and directly stimulating the remaining functional cells, retinal implants offer a promising approach for restoring vision in individuals with advanced retinal degeneration. However, the development and deployment of artificial retina devices entail addressing numerous technical, biological, and clinical challenges, including device biocompatibility, long-term safety, surgical precision, and patient selection criteria.
The global artificial retina market operates within the context of the complex nature of retinal diseases, driven by the need for innovative solutions to address the progressive vision loss, heterogeneity, and anatomical challenges associated with these conditions. Through ongoing research, collaboration, and technological advancements, the field continues to evolve, offering hope for improved outcomes and quality of life for individuals affected by retinal degenerative diseases.
Opportunities:
- Healthcare Infrastructure Investments
- Research Collaborations
-
Wireless Communication Systems -The global artificial retina market is undergoing a transformative shift with the integration of wireless communication systems into retinal prostheses. These wireless technologies offer significant advantages, enhancing the functionality and usability of artificial retinas for patients with vision impairment.
Wireless communication systems in artificial retinas enable seamless connectivity between the retinal implant and external devices such as smartphones, tablets, or wearable controllers. This connectivity facilitates real-time adjustments to the visual input, customization of visual preferences, and remote monitoring by healthcare professionals, enhancing the overall user experience.
Wireless communication systems enable data transmission between the retinal implant and external devices, allowing for the collection of valuable patient data and performance metrics. This data can be analyzed to optimize the functionality of the retinal prosthesis, improve treatment outcomes, and tailor rehabilitation strategies to individual patient needs.
The integration of wireless communication systems also enables over-the-air software updates, eliminating the need for invasive procedures to update the retinal implant's firmware or settings. This flexibility ensures that patients can benefit from the latest advancements and improvements in artificial retina technology without undergoing additional surgical interventions.
Wireless connectivity opens up possibilities for telemedicine applications, enabling remote consultations and support for patients residing in remote areas or those unable to access specialized healthcare facilities easily. This expansion of access to care can significantly improve the quality of life for individuals with vision impairment, irrespective of their geographical location.
The incorporation of wireless communication systems into artificial retinas represents a significant advancement in the field, offering enhanced functionality, connectivity, and accessibility for patients. As technology continues to evolve, wireless-enabled retinal prostheses are expected to play a crucial role in shaping the future of vision restoration therapies, offering hope to millions of individuals worldwide.
Competitive Landscape Analysis
Key players in Global Artificial Retina Market include.
- Aetna Inc.
- Bionic Vision Australia
- Nano Retina
- Optobionics
- Pixium Vision
- Retina Implant AG
- Second Sight
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Retinal Prosthesis Devices
- Market Snapshot, By Visual Prosthesis
- Market Snapshot, By Mechanical Technology
- Market Snapshot, By End-Use
- Market Snapshot, By Region
- Global Artificial Retina Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Research and development
-
Healthcare infrastructure
-
Government initiatives
-
Reimbursement policies
-
-
Restraints
-
High treatment costs
-
Long-term clinical evidence
-
Variability in patient responses
-
Complex nature of retinal diseases
-
- Opportunities
-
Healthcare Infrastructure Investments
-
Research Collaborations
-
Wireless Communication Systems
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Artificial Retina Market, By Type, 2021 - 2031 (USD Million)
- Epiretinal Implants
- Subretinal Implants
- Suprachoroidal Implants
- Others
- Global Artificial Retina Market, By Retinal Prosthesis Devices, 2021 - 2031 (USD Million)
- Photovoltaic Retinal Prosthesis
- Microelectronic Retinal Prosthesis
- Global Artificial Retina Market, By Visual Prosthesis, 2021 - 2031 (USD Million)
- Standalone Visual Prosthesis
- Combination Visual Prosthesis
- Global Artificial Retina Market, By Mechanical Technology, 2021 - 2031 (USD Million)
- Subretinal Implants
- Epiretinal Implants
- Global Artificial Retina Market, By End-Use, 2021 - 2031 (USD Million)
- Hospitals
- Ophthalmic Clinics
- Research Institutes
- Others
- Global Artificial Retina Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Artificial Retina Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Aetna Inc.
- Bionic Vision Australia
- Nano Retina
- Optobionics
- Pixium Vision
- Retina Implant AG
- Second Sight
- Company Profiles
- Analyst Views
- Future Outlook of the Market